3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
3
Inflammation
2
Glioblastoma
2
Frailty
2
Recurrence
1
Polycystic Ovary Syndrome
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Myofibroma
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Hodgkin Disease
1
Hemorrhage
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Anemia
1
Adenomyosis
1
Adenocarcinoma
1
Interventions
Cyclophosphamide
3
regorafenib
2
Proton Therapy
2
Methods
2
Gemcitabine
2
Doxorubicin
2
tocilizumab
1
poly ICLC
1
pembrolizumab
1
liposomal doxorubicin
1
lenvatinib
1
fludarabine
1
flt3 ligand protein
1
endostar protein
1
alectinib
1
aldesleukin
1
Weight-Bearing
1
Transcranial Direct Current Stimulation
1
Taxes
1
Surveys and Questionnaires
1
Standard of Care
1
Restraint, Physical
1
Range of Motion, Articular
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Quality of Life
1
Psychology, Positive
1
Platinum
1
Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
Ascorbic Acid
×
1 year
×
Clear all
No trials found.